Learning to Speak HEOR

As one formulary decision-maker told us: “Recent regulation guidance on FDAMA114 frees up pharma ...

Preparing for Possible Changes to Medicare Part D

Even prior to the midterm elections, the Trump administration has been proposing several changes ...

Is Step Therapy Now a Possibility for Part B Drugs?

The Trump administration’s drug cost blueprint looked at the possibility of moving Part B ...

Seize the Day

The multiple forces dramatically reshaping the healthcare industry show no sign of abating. Influence ...

Breaking Opioid Addiction

Despite growing awareness of the dangers around opioid overuse, 30% of all people in ...

The Impact of Express Scripts’ 2019 Formulary Exclusion List

Earlier this month, Express Scripts announced its 2019 National Preferred Formulary (NPF), which added ...

Prescription Pushback

In value-based healthcare, health plans/PBMs, employers, and government-sponsored healthcare programs focus on optimizing patient ...

Creating Value in Bundled Payments

A debate has been brewing over the past few years surrounding the Center for ...

The Payer Landscape is Evolving—But Change is Slow

Payers are evolving. Just look at the recent deals that blend together some combination ...